The evolving role of sirolimus in renal transplantation

被引：17

作者：

Dupont, P ^{[1
]}

Warrens, AN ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England

来源：

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE | 2003年 / 96卷 / 06期

关键词：

D O I：

10.1093/qjmed/hcg072

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In summary, sirolimus is an exciting addition to our immunosuppressive armamentarium. There are encouraging early data suggesting that this drug may have significant advantages over existing agents, namely the promotion of tolerance, reduction in chronic allograft vasculopathy and avoidance of toxic effects of other immunosuppressive drugs. If further large clinical studies can confirm its safety and efficacy over a longer duration of follow-up this will no doubt promote its more widespread adoption.

引用

页码：401 / 409

页数：9

共 65 条

[21] Ig receptor binding protein 1 (α4) is associated with a rapamycin-sensitive signal transduction in lymphocytes through direct binding to the catalytic subunit of protein phosphatase 2A
Inui, S
Sanjo, H
Maeda, K
Yamamoto, H
Miyamoto, E
Sakaguchi, N
[J]. BLOOD, 1998, 92 (02) : 539 - 546
[22] BCR signal through α4 is involved in S6 kinase activation and required for B cell maturation including isotype switching and V region somatic hypermutation
Inui, S
Maeda, K
Hua, DR
Yamashita, T
Yamamoto, H
Miyamoto, E
Aizawa, S
Sakaguchi, N
[J]. INTERNATIONAL IMMUNOLOGY, 2002, 14 (02) : 177 - 187
[23] Drug eluting coronary stents - May sound the death knell for restenosis
Jenkins, NP
Prendergast, BD
Thomas, M
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7376): : 1315 - 1316
[24] PRECLINICAL EVALUATION OF A NEW POTENT IMMUNOSUPPRESSIVE AGENT, RAPAMYCIN
KAHAN, BD
CHANG, JY
SEHGAL, SN
[J]. TRANSPLANTATION, 1991, 52 (02) : 185 - 191
[25] Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: A phase II trial
Kahan, BD
Julian, BA
Pescovitz, MD
Vanrenterghem, Y
Neylan, J
[J]. TRANSPLANTATION, 1999, 68 (10) : 1526 - 1532
[26] Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation
Kahan, BD
Podbielski, J
Napoli, KL
Katz, SM
Meier-Kriesche, HU
Van Buren, CT
[J]. TRANSPLANTATION, 1998, 66 (08) : 1040 - 1046
[27] Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
Kahan, BD
[J]. LANCET, 2000, 356 (9225) : 194 - 202
[28] KAY JE, 1991, IMMUNOLOGY, V72, P544
[29] KNIGHT R, 1993, TRANSPLANTATION, V55, P947
[30] Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients
Kreis, H
Cisterne, JM
Land, W
Wramner, L
Squifflet, JP
Abramowicz, D
Campistol, JM
Morales, JM
Grinyo, JM
Mourad, G
Berthoux, FC
Brattström, C
Lebranchu, Y
Vialtel, P
[J]. TRANSPLANTATION, 2000, 69 (07) : 1252 - 1260

← 1 2 3 4 5 6 7 →